226 related articles for article (PubMed ID: 9744510)
1. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Hinnen P; de Rooij FW; van Velthuysen ML; Edixhoven A; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
Br J Cancer; 1998 Sep; 78(5):679-82. PubMed ID: 9744510
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Hinnen P; de Rooij FW; Terlouw EM; Edixhoven A; van Dekken H; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
Br J Cancer; 2000 Aug; 83(4):539-43. PubMed ID: 10945504
[TBL] [Abstract][Full Text] [Related]
3. Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures.
Hinnen P; Siersema PD; Edixhoven A; Wilson JH; de Rooij FW
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):903-9. PubMed ID: 12699249
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C
Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815
[TBL] [Abstract][Full Text] [Related]
5. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
6. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
Hinnen P; de Rooij FW; Hop WC; Edixhoven A; van Dekken H; Wilson JH; Siersema PD
J Photochem Photobiol B; 2002 Aug; 68(1):8-14. PubMed ID: 12208031
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia.
Tan WC; Fulljames C; Stone N; Dix AJ; Shepherd N; Roberts DJ; Brown SB; Krasner N; Barr H
J Photochem Photobiol B; 1999; 53(1-3):75-80. PubMed ID: 10672532
[TBL] [Abstract][Full Text] [Related]
9. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
10. Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract.
Bourre L; Thibaut S; Briffaud A; Lajat Y; Patrice T
Pharmacol Res; 2002 Feb; 45(2):159-65. PubMed ID: 11846630
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
Dunn J; Lovat L
Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960
[TBL] [Abstract][Full Text] [Related]
12. Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus.
van den Boogert J; Houtsmuller AB; de Rooij FW; de Bruin RW; Siersema PD; van Hillegersberg R
Lasers Surg Med; 1999; 24(1):3-13. PubMed ID: 10037346
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Claydon PE; Ackroyd R
Dis Esophagus; 2004; 17(3):205-12. PubMed ID: 15361092
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
Ackroyd R; Brown N; Vernon D; Roberts D; Stephenson T; Marcus S; Stoddard C; Reed M
Photochem Photobiol; 1999 Oct; 70(4):656-62. PubMed ID: 10546561
[TBL] [Abstract][Full Text] [Related]
15. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.
Regula J; MacRobert AJ; Gorchein A; Buonaccorsi GA; Thorpe SM; Spencer GM; Hatfield AR; Bown SG
Gut; 1995 Jan; 36(1):67-75. PubMed ID: 7890239
[TBL] [Abstract][Full Text] [Related]
16. [Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Ortner M; Lochs H
Z Gastroenterol; 1998 Jan; 36(1):111-3. PubMed ID: 9531692
[No Abstract] [Full Text] [Related]
17. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.
Kelty CJ; Ackroyd R; Brown NJ; Brown SB; Reed MW
Surg Endosc; 2004 Mar; 18(3):452-8. PubMed ID: 14752635
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.
Messmann H; Knüchel R; Bäumler W; Holstege A; Schölmerich J
Gastrointest Endosc; 1999 Jan; 49(1):97-101. PubMed ID: 9869731
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
Gossner L; Stolte M; Sroka R; Rick K; May A; Hahn EG; Ell C
Gastroenterology; 1998 Mar; 114(3):448-55. PubMed ID: 9496934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
